A breakthrough: Macrophage-directed cancer immunotherapy

Cancer Research

Volumn 76, Issue 3, 2016, Pages 513-516

  Mills, Charles D ^a   Lenz, Laurel L ^b   Harris, Robert A ^c  

^a BioMedical Consultants   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

CANCER GROWTH; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER SUSCEPTIBILITY; CELL KILLING; CYTOTOXIC T LYMPHOCYTE; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; MACROPHAGE; MACROPHAGE ADAPTIVE CONVERSION THERAPY; MACROPHAGE INNATE CONVERSION THERAPY; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; TH1 CELL; WOUND HEALING; ANIMAL; IMMUNOLOGY; IMMUNOTHERAPY; NEOPLASMS; PATHOLOGY; PROCEDURES;

ANIMALS; HUMANS; IMMUNOTHERAPY; MACROPHAGES; NEOPLASMS;

EID: 84958231592     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-15-1737     Document Type: Review

References (29)

1. Cavaillion JM. The historical milestones in the understanding of leukocyte biology initiated by Elie Metchinikoff. J Leuk Biol 2011;90:413-24.
2. Erhlich P. Uber den jetzigen Stand der Karzinomforschung. In:Himmelweit F, editor. The collected papers of Paul Erlich. London: Pergamon Press; 1957 Vol II. p. 550-62.
3. Thomas JA, Badini M. The role of innate immunity in the spontaneous regression of cancer. Int J Cancer 2011;48:246-51
4. Mills CD, North RJ. Expression of passively transferred immunity against an established tumor depends on the generation of cytolytic T cells in the recipient. Inhibition by suppressor T cells. J Exp Med 1983;157:1448-60.
5. Todaro GJ. Parke-Davis Award lecture. Evolution and modes of transmission of RNA tumor viruses. Am J Pathol 1975;81:590-606.
6. Mills CD. M1 andM2Macrophages: oracles of health and disease. Crit Rev Immunol 2012;32:463-88.
7. Stutman O. Tumor development after 3-methylcholanthrene in immunologically deficient athymic-nude mice. Science 1974;183:534-6.
8. Prehn RT. The immune reaction as a stimulator of tumor growth. Science 1972;176:170-1.
9. Rosenberg SA, Restifo NP. Adoptive cell transfer as personalized immunotherapy for human cancer. Science 2015;348:62-8.
10. Albina JE, Mills CD, Henry WL Jr., Caldwell MD. Temporal expression of different pathways of 1-Arginine metabolism in healing wounds. J Immunol 1990;144:3877-80.
11. Mills CD, Shearer J, Evans R, Caldwell MD. Macrophage arginine metabolism and the inhibition or stimulation of cancer. J Immunol 1992; 149:2709-14.
12. Mills CD. Anatomy of a discovery: M1 and M2 macrophages. Front Immunol 2015;6:212
13. Mackaness GB. The immunological basis of acquired cellular resistance. J Exp Med 1964;120:105-20.
14. Hibbs JB, Vavrin Z, Taintor RR. L-Arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol 1987;138:550-65.
15. Mills CD. Macrophage arginine metabolism to ornithine/urea or nitric oxide/citrulline: A life or death issue. Crit Rev Immunol 2001;21:399-425.
16. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 2000;164:6166-73.
17. Noy R, Pollard JW. Tumor-Associated macrophages: from mechanisms to therapy. Immunity 2014;41:49-61.
18. Ruffell B, Coussens LM. Macrophages and therapeutic resistance in cancer. Cancer Cell 2015;13:462-72.
19. Beatty GL, Chiorean EG, Fishman MP, Saboury B, Teitelbaum UR, Sun W, et al. CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science 2011; 331:1612-6.
20. O'Sullivan T, Saddawi-Konefka R, Vermi W, Koebel CM, Arthur C, White JM, et al. Cancer immunoediting by the innate immune system in the absence of adaptive immunity. J Exp Med 2012;209: 1869-82.
21. Evans JT, Shows TB, Sproul EE, Paolini NS, Mittelman A, Hauschka TS. Genetics of colon carcinogenesis in mice treated with 1, 2-dimethylhydrazine. Cancer Res 1977;37:134-6.
22. Robert J. Comparative study of tumorigenesis and tumor immunity in invertebrates and nonmammalian vertebrates. Dev Comp Immunol 2010;34:915-25.
23. Wang J, Cao Z, Zhang XM, Nakamura M, Sun M, Hartman J, et al. Novel mechanism of macrophage-mediated metastasis revealed in a zebrafish model of tumor development. Cancer Res 2015;75:306-15.
24. Mills CD, Ley K, Buchmann K, Canton J. Sequential immune responses: The weapons of immunity. J Innate Immun 2015;7:443-9.
25. Shevach EM, Rosenthal AS. Function of macrophages in antigen recognition by guinea pig T lymphocytes. II. Role of the macrophage in the regulation of genetic control of the immune response. J Exp Med 1973;138: 1213-29.
26. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997;388:394-7.
27. Geissmann F, Gordon S, Hume DA,Mowat DA, Randolph GJ. Unravelling mononuclear phagocyte heterogeneity. Nat Rev Immunol 2010;10:453-60.
28. Albina JE, Caldwell MS, Henry WL, Mills CD. Regulation of macrophage functions by L-Arginine. J Exp Med 1989;169:1021-9.
29. Mills CD, Ley K. M1 and M2 Macrophages: The chicken and the egg of immunity. J Innate Immun 2014;6:716-26.